|
Letermovir for cytomegalovirus prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation : a single-center experience
|
Pai-Lin Tsai, Meng-Yao Lu, Hsiu-Hao Chang, Yung-Li Yang, Chia-Jui Du, Chang-Hsueh Wu, Shiann-Tarng Jou, Shu-Wei Chou
|
p. 1-6
|
|
|
|
|
|
Comparative evaluation of two NGS-based assays for somatic hypermutation analysis of IGHV genes in chronic lymphocytic leukemia
|
Yehyun Kang, Hyeonah Lee, Yu Jin Park, SeungTae Lee, Jong Rak Choi, Saeam Shin
|
p. 1-7
|
|
|
|
|
|
Autologous bone marrow transplantation in non-Hodgkin lymphoma patients following different conditioning regimens : an 11-year single-center quasi-experimental study
|
Sahar Tavakoli Shiraji, Mohammad Biglari, Soroush Rad, Maryam Barkhordar, Hossein Kamranzadeh Foumani, Ghasem Janbabaei, Seied Asadollah Mousavi, Mohammad Vaezi, Kamran Mohammadi, Ardeshir Ghavamzadeh
|
p. 1-9
|
|
|
|
|
|
Discordance between immunofixation and free light chain assays in multiple myeloma : a retrospective analysis and evaluation of the heavy/light chain assay for disease monitoring
|
Oytip Nathalang, Yupapin Onthong, Chonlada Laoruangroj, Dollapak Apipongrat
|
p. 1-11
|
|
|
|
|
|
Monitoring of JAK2V617F allele burden in patients with essential thrombocythemia
|
Jeong Suk Koh, Wonhyoung Seo, Sora Kang, Myung-Won Lee, Hyewon Ryu, Seung-Woo Baek, Ik-Chan Song, Hyo-Jin Lee, Deog-Yeon Jo
|
p. 1-9
|
|
|
|
|
|
Prognostic significance of PNH clones in aplastic anemia treated with immunosuppression or allogeneic HSCT : a 20-year single-center experience
|
Alfadil Haroon, Hazzaa Alzahrani, Mostafa F. Mohammed Saleh, Ali Aalahmari, Shaykhah Alotaibi, Tusneem Elhassan, Feras Alfraih, Fahad Alsharif, Syed O. Ahmed, Fahad Almohareb, Riad El Fakih, Mahmoud Aljurf
|
p. 1-8
|
|
|
|
|
|
Checkpoint inhibitor–induced hematologic immune-related adverse events and their association with disease recurrence in hematolymphoid malignancies : a clinical perspective
|
Chokri Ben Lamine, Amr Hanbali, Ghada ElGohary, Hanan Alkhaldi, Riad El Fakih, Mahmoud Aljurf
|
p. 1-10
|
|
|
|
|
|
Deregulation of stemness and senescence genes in bone marrow mesenchymal stem cells of multiple myeloma : implications for therapeutic approaches
|
Fatemeh Soleymani, Saeideh Kavousi, Nastaran Khodakarim, Mohammad Ahmadvand
|
p. 1-10
|
|
|
|
|
|
Exploring CD79b, LC3, and TERT expression in NON-GCB DLBCL : markers associated with Rituximab-Cyclophosphamide-Doxorubicin-Vincristin-Prednisone treatment response
|
Bethy S. Hernowo, Arnita Ilanur, Hasrayati Agustina, Amaylia Oehadian, Birgitta M. Dewayani, Anglita Yantisetiasti, Hermin A. Usman, Etis Primastari, Okky Husain, Nia Nuraeni, Nurvita Trianasari
|
p. 1-10
|
|
|
|
|
|
(Correspondence) Dynamic, anthracycline-induced chromatin alterations enable ALDH1 expression as a mechanism of inducible leukemia resistance development
|
Spiros A. Vlahopoulo
|
p. 1-5
|
|
|
|
|
|
Targeting the HERV‑K102 envelope elicits pyroptosis and represents a novel therapeutic strategy for acute myeloid leukemia
|
Lihong Zong, Qian Luo, Jingru Zhao, Huyi Lei, Hui Liu, Mengyuan Li, Yiyuan Chen, Minghuan Zhang, Rongzhen Xu, Wenbin Qian
|
p. 1-10
|
|
|
|
|
|
(Correspondence) A strategic approach to managing Immune Effector Cell‑Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T‑cell therapy
|
Sang Eun Yoon
|
p. 1-2
|
|
|
|
|
|
(Correspondence) A mitochondrial‑based prognostic score for risk stratification in acute myeloid leukemia
|
Isabelle C. Santos, Vitória J. Silva‑Xavier, , Amanda Moreira‑Aguiar, Marcio T. Reis‑Silva, Lidiane P. Silva, Pedro L. França‑Neto, Marcos A. Bezerra, João A. Machado‑Neto, Diego A. Pereira‑Martins, Antonio R. Lucena‑Araujo, Juan L. Coelho‑Silva
|
p. 1-6
|
|
|
|
|
|
Real : world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations
|
Lin Yun-Tzu, Tsai Xavier Cheng-Hong, Tien Feng-Ming, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Liu Jia-Hau, Ko Bor-Sheng, Cheng Chieh-Lung, Chou Sheng-Chieh, Lin Ming-En, Lin Chien-Chin, Chuang Ming-Kai, Yao Ming, Hou Hsin-An, Chou Wen-Chien, Tien Hwei-Fang
|
p. 26-26
|
|
|
|
|
|
Allogeneic stem cell transplantation for myelofibrosis in the modern era : Single-center outcomes with DIPSS risk stratification
|
Choi Dae-Ho, Jang Jun Ho, Jung Chul Won
|
p. 27-27
|
|
|
|
|
|
Enlarged splenic volume predicts poor survival and is associated with inflammatory imbalance in patients with diffuse large B : cell lymphoma
|
Qiu Zongjian, Jiang Rifeng, Wu Shunquan, Zhan Rong, Hu Xiaomei, Wang Shaoyuan
|
p. 28-28
|
|
|
|
|
|
The role of impaired bone marrow Tregs in hematopoietic stem cell depletion for pediatric aplastic anemia probably involves immune privilege
|
Huang Can, Li Shanshan, Yang Jingwei, Jiao Yangyang, Zhang Ting, Jiang Hui, Zeng Fanyi, Jiang Shayi
|
p. 29-29
|
|
|
|
|
|
Infectious complications after CAR T-cell therapy : mechanisms, risk stratification, and prevention
|
Lee Eunseuk, Lee Ji Hyun, Kim Hye Ryeon, Huh Seok Jae, Lee Suee, Oh Sung-Yong, Kim Sung-Hyun, Lee Hojin
|
p. 30-30
|
|
|
|
|
|
Novel treatment strategies in acute myeloid leukemia
|
Simkhada Shailesh, Joshi Utsav, Dhakal Prajwal
|
p. 31-31
|
|
|
|
|
|
Cross : cultural validation and reliability of the Korean version of the Haemophilia Activities List
|
Kim Sung Eun, Shim Ye Jee, Yoon Hwi-Joong, Park Sang Kyu, Yoo Ki-Young, Choi Eun Jin, Kim Ji Yoon
|
p. 32-32
|
|
|
|
|
|
Primary breast follicular lymphoma without a BCL2 rearrangement : insights into extranodal lymphoma biology
|
Seth Neha, Khan Anam, Zhong Elaine, Tam Wayne
|
p. 33-33
|
|
|
|
|
|
Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65–75 years : a real-world study
|
Lee Naryllae, Kim Seoyeon, Lee Yugyeong, Park Sin Young, Cho Hyunsoo, Byun Ja Min, Koh Youngil, Hong Junshik, Shin Dong-Yeop, Min Chang-Ki, Byeon Seonggyu, Park Sung-Soo, Kim Dong Hyun
|
p. 34-34
|
|
|
|
|
대표어
한국학술지인용색인(NRF)
